Advisers to F.D.A. Vote Against Duchenne Muscular Dystrophy Drug. Muscular Dystrophy, Pollack, Andrew, Food and Drug Administration, Drugs (Pharmaceuticals), Sarepta Therapeutics Inc., Clinical Trials